ADMA Biologics Earnings
NASDAQ: ADMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 2:49 PM ET
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$0.19
ADMA Biologics earnings summary
ADMA Biologics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $0.19. In its most recent report on Aug 5, 2026 (Q2 2026), ADMA posted EPS of $0.16. Revenue for the quarter was $124.4 million.
Quarterly EPS is up 14.3% from the same quarter a year earlier. Across the last 16 reports, ADMA shares moved an average of 5.4% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
ADMA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $0.16 | — | -4.3% |
| May 6, 2026 | — | $0.19 | — | +1.2% |
| Feb 25, 2026 | — | $0.20 | — | -1.2% |
| Nov 5, 2025 | — | $0.15 | — | +7.2% |
| Aug 6, 2025 | — | $0.14 | — | +2.8% |
| May 7, 2025 | — | $0.11 | — | -1.5% |
| Mar 18, 2025 | — | $0.45 | — | +2.3% |
| Nov 7, 2024 | — | $0.15 | — | -15.8% |
| Aug 8, 2024 | — | $0.13 | — | +10.0% |
| May 9, 2024 | — | $0.08 | — | +4.5% |
| Feb 28, 2024 | — | $-0.08 | — | +14.9% |
| Nov 8, 2023 | — | $0.01 | — | +5.3% |
| Aug 9, 2023 | — | $-0.03 | — | -8.5% |
| May 10, 2023 | — | $-0.03 | — | -2.8% |
| Mar 23, 2023 | — | $-0.05 | — | -0.3% |
| Nov 9, 2022 | — | $-0.08 | — | -4.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.